FR2809623B1 - Dans le traitement des maladies neurodegeneratives : (notamment alzheimer et parkinson), utilisation pour un medicament : du sildenafil (ou de ses derives) - Google Patents
Dans le traitement des maladies neurodegeneratives : (notamment alzheimer et parkinson), utilisation pour un medicament : du sildenafil (ou de ses derives)Info
- Publication number
- FR2809623B1 FR2809623B1 FR0013992A FR0013992A FR2809623B1 FR 2809623 B1 FR2809623 B1 FR 2809623B1 FR 0013992 A FR0013992 A FR 0013992A FR 0013992 A FR0013992 A FR 0013992A FR 2809623 B1 FR2809623 B1 FR 2809623B1
- Authority
- FR
- France
- Prior art keywords
- sildenafil
- parkinson
- derivatives
- treatment
- neurodegenerative diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0013992A FR2809623B1 (fr) | 2000-06-05 | 2000-10-31 | Dans le traitement des maladies neurodegeneratives : (notamment alzheimer et parkinson), utilisation pour un medicament : du sildenafil (ou de ses derives) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007161A FR2809622A1 (fr) | 2000-06-05 | 2000-06-05 | Dans le traitement des maladies neurodegeneratives ( notamment alhzeimer et parkinson) utilisation pour un medicament: du sildenafil (ou de ses derives) ou, de la nicotine et du sildenafil (ou des derives des deux) |
FR0013992A FR2809623B1 (fr) | 2000-06-05 | 2000-10-31 | Dans le traitement des maladies neurodegeneratives : (notamment alzheimer et parkinson), utilisation pour un medicament : du sildenafil (ou de ses derives) |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2809623A1 FR2809623A1 (fr) | 2001-12-07 |
FR2809623B1 true FR2809623B1 (fr) | 2003-09-05 |
Family
ID=27758814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0013992A Expired - Fee Related FR2809623B1 (fr) | 2000-06-05 | 2000-10-31 | Dans le traitement des maladies neurodegeneratives : (notamment alzheimer et parkinson), utilisation pour un medicament : du sildenafil (ou de ses derives) |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2809623B1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006224623A1 (en) * | 2005-03-14 | 2006-09-21 | Nycomed Gmbh | Method for preventing cardiovascular diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE262899T1 (de) * | 1996-01-02 | 2004-04-15 | Aventis Pharma Inc | Substituierte (aryl, heteroaryl, arylmethyl oder heteroarylmethyl) hydroxamisaeureverbindungen |
US6007824A (en) * | 1998-07-09 | 1999-12-28 | Duckett; Melvin J. | Natural composition and method for the treatment of sexual dysfunction |
AU779761C (en) * | 1999-10-12 | 2005-09-22 | Lilly Icos Llc | Medicament for treatment of neuropathies |
IL152925A (en) * | 1999-10-21 | 2010-04-15 | Pfizer | Pharmaceutical preparations for the treatment of neurological disease containing an inhibitor of ring guanizine '3', 5 '- monophosphate phosphodiesterase 5 and one of gabapentin or pregabalin |
-
2000
- 2000-10-31 FR FR0013992A patent/FR2809623B1/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR2809623A1 (fr) | 2001-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1651195A4 (fr) | Procedes pharmaceutiques, posologies et formes posologiques pour le traitement de la maladie d'alzheimer | |
YU37602A (sh) | Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns | |
NL300258I2 (nl) | Farmaceutische samenstelling voor toepassing in debehandeling van. | |
WO1997048391A3 (fr) | Methodes et compositions a base de r-ibuprofene | |
DE60100866D1 (de) | Cyklosporin, Hyaluronsäure und Polysorbate enthaltenes Augenarzneimittel | |
NO324227B1 (no) | Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer | |
DE60235719D1 (de) | Frauenhygieneartikel zur verabreichung von arzneimittel | |
DE60126321D1 (de) | Gelsystem zur ocularen verabreichung von arzneimitteln | |
BRPI0407662B8 (pt) | derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
CA2431565A1 (fr) | Nouvelles compositions pharmaceutiques a base d'anticholinergiques et de ciclesonide | |
HUP0401867A2 (hu) | A valproinsav-amid és a 2-valproénsav-amid származékainak használata a fájdalommal és a fejfájással járó betegségek kezelésére vagy megelőzésére | |
IL152578A0 (en) | Ortho-substituted anthranilic acid amides and their use as medicaments | |
IS6394A (is) | Lyfjablanda sem inniheldur solmítriptan | |
DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
AU2002212471A1 (en) | Peptides for use in the treatment of alzheimer's disease | |
NO323466B1 (no) | Nye kinolinyl-piperidin-4-yliden-metyl-benzamidderivater, fremgangsmate til fremstilling derav, anvendelse derav i medikamenter til behandling av smerte, samt farmasoytisk sammensetning som innbefatter slike derivater | |
EP0676200A3 (fr) | Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales. | |
EP0657167A3 (fr) | Application de l'oenothéine B pour obtenir un médicament destiné au traitement des troubles liés à l'hyperandrogénie, les compositions pharmaceutiques le contenant et un procédé de préparation à partir d'Epilobium Parviflorum. | |
FR2809623B1 (fr) | Dans le traitement des maladies neurodegeneratives : (notamment alzheimer et parkinson), utilisation pour un medicament : du sildenafil (ou de ses derives) | |
HUP0200145A2 (hu) | Tianeptin alkalmazása neurodegeneratív betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
FR2810886B1 (fr) | Dans le traitement des maladies neurodegeneratives : (notamment alzheimer et parkinson), utilisation pour un medicament : de la nicotine et du sildenafil (ou des derives des deux) | |
PL362566A1 (en) | Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases | |
IL153439A0 (en) | Medicines for the prevention and treatment of neurodegenerative diseases | |
AU2001262741A1 (en) | Medicines for the prevention and treatment of neurodegenerative diseases | |
FR2792319B1 (fr) | Procede de preparation de monosulfate de 4 ou 6 disaccharides, leur utilisation en cosmetique et en tant que medicament notamment pour le traitement des maladies du collagene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20060630 |
|
D3 | Decision to revoke the decision of lapse | ||
CA | Change of address | ||
ST | Notification of lapse |
Effective date: 20140630 |